| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/06/2000 | EP1033575A2 Device for carrying out lateral-flow assays involving more than one analyte |
| 09/06/2000 | EP1033574A2 Morphogenic protein screening method |
| 09/06/2000 | EP1033573A2 Automated analyzing system and method thereof |
| 09/06/2000 | EP1033566A1 Method and device for disintegrating biological material |
| 09/06/2000 | EP1033411A2 Fluorescent donor-acceptor pair |
| 09/06/2000 | EP1033404A1 New gene with down-regulated expression in metastatic human melanoma cells |
| 09/06/2000 | EP1033403A1 Gene originating in human fetal chondrocytes |
| 09/06/2000 | EP1033169A1 Sorbent cartridge for solid phase extraction |
| 09/06/2000 | EP1033137A1 Diagnostics for complications of diabetes or renal insufficiency |
| 09/06/2000 | EP1033135A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens |
| 09/06/2000 | EP1033134A1 Compositions inhibiting smooth muscle proliferation, method for the diagnosis of arteriosclerosis, and kits therefor |
| 09/06/2000 | EP1032839A2 Method for automatic implementation of chemical or biological methods |
| 09/06/2000 | EP1032837A1 Target sequences for synthetic molecules and methods of using same |
| 09/06/2000 | EP1032836A1 Device and method for detecting analytes |
| 09/06/2000 | EP1032835A1 Improvements in or relating to displacement assays |
| 09/06/2000 | EP1032834A1 Nuclear hormone receptor drug screens |
| 09/06/2000 | EP1032832A1 Methods and apparatus for determining beta radiation spectra |
| 09/06/2000 | EP1032831A1 Method and device for detecting dirt as present on articles, for example eggs |
| 09/06/2000 | EP1032826A1 Method for producing laterally organized structures on supporting surfaces |
| 09/06/2000 | EP1032825A1 Improvements in or relating to electrochemical assays |
| 09/06/2000 | EP1032822A1 Apparatus for reading a plurality of biological indicators |
| 09/06/2000 | EP1032820A1 Self-contained assay device and method |
| 09/06/2000 | EP1032819A1 Method for differentiation of erythroblasts |
| 09/06/2000 | EP1032818A1 Method for differentiation of erythroblasten |
| 09/06/2000 | EP1032817A1 Automatic hematologic counting and analysing device |
| 09/06/2000 | EP1032813A2 Apparatus and methods for measuring fluorescence polarization |
| 09/06/2000 | EP1032709A1 Method and apparatus for preserving human saliva for testing |
| 09/06/2000 | EP1032708A1 Nucleic acid ligands of tissue target |
| 09/06/2000 | EP1032706A1 Reagents and methods useful for detecting diseases of the breast |
| 09/06/2000 | EP1032700A1 Separation of nucleic acids by antibodies to halogenated nucleotides |
| 09/06/2000 | EP1032687A2 Human cdnas encoding polypeptides having kinase functions |
| 09/06/2000 | EP1032682A1 Desaturase genes and their use |
| 09/06/2000 | EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032675A1 Attaching substances to micro-organisms |
| 09/06/2000 | EP1032674A2 $i(CHLAMYDIA PNEUMONIAE) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032666A1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN |
| 09/06/2000 | EP1032665A1 A human 2-19 protein homologue, z219c |
| 09/06/2000 | EP1032660A1 Method of identifying binding site domains that retain the capacity of binding to an epitop |
| 09/06/2000 | EP1032649A1 deoD |
| 09/06/2000 | EP1032597A1 Methods for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 09/06/2000 | EP1032588A1 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors |
| 09/06/2000 | EP1032582A1 NOVEL recJ |
| 09/06/2000 | EP1032562A2 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032420A1 Immunoglobulin molecules having a synthetic variable region and modified specificity |
| 09/06/2000 | EP1032387A1 Novel metal complexes |
| 09/06/2000 | EP1032307A1 Analytic measuring device with a puncturing aid |
| 09/06/2000 | EP1032303A1 Methods, kits, electrodes and compositions for assessing the level of an analyte of interest in fluid samples |
| 09/06/2000 | EP1032271A1 Purging of stem cell products |
| 09/06/2000 | EP1032269A1 Treatment of neoplasms with viruses |
| 09/06/2000 | EP0901379B1 Type-2 chemokine binding proteins and methods of use therefor |
| 09/06/2000 | EP0854934A4 Detection of organic compounds through regulation of antibody-catalyzed reactions |
| 09/06/2000 | EP0809806A4 Monoclonal antibodies for human osteogenic cell surface antigens |
| 09/06/2000 | EP0770089B1 Growth differentiation factor-12 |
| 09/06/2000 | EP0641222B1 TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING |
| 09/06/2000 | EP0631502B1 Lymphocyte activity regulation by hla peptides |
| 09/06/2000 | EP0630475B1 Red blood cell separation means for specific binding assays |
| 09/06/2000 | EP0518996B1 Monitoring of soil |
| 09/06/2000 | EP0504388B1 Varicella-zoster virus antigen |
| 09/06/2000 | CN2395277Y Combined quick diagnostic reaction board for antigen echinococcosis |
| 09/06/2000 | CN2395276Y Self walking barn data detector |
| 09/06/2000 | CN1265741A Method and compositions for overcoming resistance to biologic and chemotherapy |
| 09/06/2000 | CN1265740A Use of oxidative stress disagnostic plot as health indicator for assessing oxidative stress and its control in humans |
| 09/06/2000 | CN1265707A Solid support with attached molecules |
| 09/06/2000 | CN1265701A Cleaning articles comprising cellulosic fibrous structure having discrete low basis weight regions and inverse emulsion |
| 09/06/2000 | CN1265666A Oxidized styrenic polymer for DNA binding |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265572A Method of imaging cell death in vivo |
| 09/06/2000 | CN1265566A Method and apparatus for disruption of biological material |
| 09/06/2000 | CN1265469A Method and device for evaluating quality of grain |
| 09/05/2000 | US6115061 In situ microscope imaging system for examining subsurface environments |
| 09/05/2000 | US6114964 Systems and methods for fenceline air monitoring of airborne hazardous materials |
| 09/05/2000 | US6114540 Spiro[pyrrolidine-2,3'-oxindole] compounds and methods of use |
| 09/05/2000 | US6114516 Nucleotide sequences coding for variable regions of the αchains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic muses |
| 09/05/2000 | US6114515 PIGRL-1, a member of immunoglobulin gene superfamily |
| 09/05/2000 | US6114508 Cocaethylene immunogens and antibodies |
| 09/05/2000 | US6114506 Composition and method for enhancing fibrinolysis |
| 09/05/2000 | US6114350 Cyanine dyes and synthesis methods thereof |
| 09/05/2000 | US6114323 Diabetic kidney disease; administering aminoguanidine |
| 09/05/2000 | US6114180 Human cardiac troponin |
| 09/05/2000 | US6114179 Method and test kit for detecting antigens and/or antibodies |
| 09/05/2000 | US6114177 Contacting with 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene fluorophore |
| 09/05/2000 | US6114176 Method for measuring the concentration of a substance in a solution |
| 09/05/2000 | US6114175 Amyloid-binding compounds which are non-azo derivatives of chrysamine g to determine degree of brain deposits quantitatively characterized by amyloidosis; down's syndrome; prevent cell degeneration; radioactive imaging |
| 09/05/2000 | US6114174 In-vitro detection of reactions in blood to foreign substances |
| 09/05/2000 | US6114173 Accurate light scatter/absorption flow cytometry process using automated hematology analyzer with no sample preparation time; uses aqueous reagent including cationic dye, zwitterionic surfactant and buffer |
| 09/05/2000 | US6114172 Simple, quick method by introducing predetermined amount of sample into biological bath filled with oxygen-saturated dilution water, measuring oxygen consumption per unit of time, rinsing bath with neutral dilution water from another source |
| 09/05/2000 | US6114170 Mixture of one or more ph buffers, one or more ph indicators, and one or more surfactants; color change indicating strength is directly dependent on specific gravity and not on a ph shift |
| 09/05/2000 | US6114144 Isolation of a gene encoding human thyrotropin β subunit |
| 09/05/2000 | US6114136 Compositions used as a pathological control in a method for the detection of resistance to activated protein C, method for the preparation of these compositions and use in said detection method |
| 09/05/2000 | US6114135 Multiple coagulation test system and method of using a multiple coagulation test system |
| 09/05/2000 | US6114134 Method for assaying biological specimens for substances contained in the components thereof and reagent to be used in this method |
| 09/05/2000 | US6114133 Detection of nervous system disorder by monitoring amino acid sequence fragments in cerebrospinal fluid and contrasting with standard |
| 09/05/2000 | US6114132 For determining the binding ability of a ligand to a cysteine-containing wild-type tyrosine phosphatase; medical diagnosis |
| 09/05/2000 | US6114131 Methods for the detection of antibodies to ornithobacterium rhinotracheale |
| 09/05/2000 | US6114130 Reagent for measurement of the haemoglobin and determination of the leukocytes in a blood sample |
| 09/05/2000 | US6114129 Evaluation of activity of lymphocytes; incubation of sample with antibodies that detect mucin expression, evaluation of mucin expression in control and sample, amplification of mucins are indicative lymphocyte activity |
| 09/05/2000 | US6114128 Screening the therapeutic response of a compound to a cell proliferation defect; detecting cells which infiltrate cancerous cells, monitoring reduction in cancerous cells and incrase in infiltrating cells |
| 09/05/2000 | US6114127 Methods of screening for agonists and antagonists of the HDPXU17 receptor |